{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.1444.3.176",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2021-03-19T01:00:22.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.176",
  "version": "20210319",
  "name": "Immunotherapy Administration",
  "status": "active",
  "date": "2021-03-19T01:00:22-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.icd10data.com/icd10pcs",
        "version": "2022",
        "concept": [
          {
            "code": "XW03351",
            "display": "Introduction of Blinatumomab Antineoplastic Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 1"
          },
          {
            "code": "XW033C3",
            "display": "Introduction of Engineered Autologous Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 3"
          },
          {
            "code": "XW04351",
            "display": "Introduction of Blinatumomab Antineoplastic Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 1"
          },
          {
            "code": "XW043C3",
            "display": "Introduction of Engineered Autologous Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 3"
          },
          {
            "code": "XW23346",
            "display": "Transfusion of Brexucabtagene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code": "XW23376",
            "display": "Transfusion of Lisocabtagene Maraleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code": "XW24346",
            "display": "Transfusion of Brexucabtagene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code": "XW24376",
            "display": "Transfusion of Lisocabtagene Maraleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 6"
          }
        ]
      }
    ]
  }
}